Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis

Tuberculosis is the leading infectious disease killer globally due to a single pathogen. Despite wide deployment of standard drug regimens, modern diagnostics and a vaccine (bacille Calmette Guerin, BCG), the global tuberculosis epidemic is inadequately controlled. Novel, effective vaccine(s) are a...

Descripción completa

Detalles Bibliográficos
Autores principales: Scriba, Thomas J., Netea, Mihai G., Ginsberg, Ann M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786643/
https://www.ncbi.nlm.nih.gov/pubmed/33279383
http://dx.doi.org/10.1016/j.smim.2020.101431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786643/
https://www.ncbi.nlm.nih.gov/pubmed/33279383
http://dx.doi.org/10.1016/j.smim.2020.101431

Ejemplares similares